Vimarsana
Biggest News Aggregation in the World

Page 5 - Conditional Marketing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Conditional Marketing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Conditional Marketing Today - Breaking & Trending Today

InClin Announces Quasar Publication Featuring First Virtual Inspection Conducted by the European Medicines Agency (EMA) - Vimarsana News

InClin Announces Quasar Publication Featuring First Virtual Inspection Conducted by the European Medicines Agency (EMA)

Press release content from Business Wire. The AP news staff was not involved in its creation. InClin Announces Quasar Publication Featuring First Virtual Inspection Conducted by the European Medicines Agency (EMA) January 20, 2021 GMT SAN MATEO, Calif.--(BUSINESS WIRE)--Jan 20, 2021-- InClin, Inc., a full-service Contract Research Organization (CRO) with offices in the San Francisco Bay Area and Sydney, Australia, today announced the publication of a manuscript entitled: “The New Norm: A Global Virtual GCP Preapproval EMA Inspection” in Issue #154 January 2021 edition of Quasar, the Resea...

Source: apnews.com
AstraZeneca vaccine hopeful to be green-lighted by EU in January - Vimarsana News

AstraZeneca vaccine hopeful to be green-lighted by EU in January

BRUSSELS, Jan. 12 (Xinhua) -- The European Medicines Agency (EMA) said on Tuesday it had received the application for conditional marketing authorization for a

EMA possible to conclude AstraZeneca vaccine assessment in January - Vimarsana News

EMA possible to conclude AstraZeneca vaccine assessment in January

BRUSSELS, Jan. 8 (Xinhua) - The assessment of COVID-19 vaccine developed by AstraZeneca and Oxford University would possibly be concluded by the end of January,

Questions and Answers: Conditional Marketing Authorisation of COVID-19 Vaccines in the EU - Vimarsana News

Questions and Answers: Conditional Marketing Authorisation of COVID-19 Vaccines in the EU

Met dank overgenomen van Europese Commissie (EC), gepubliceerd op vrijdag 11 december 2020. With which companies have you concluded COVID-19 vaccine agreements? The Commission is negotiating intensely to build a diversified portfolio of vaccines at fair prices. Contracts have been concluded with AstraZeneca (400 million doses), Sanofi-GSK (300 million doses), Johnson and Johnson (doses covering 400 million people), BioNTech-Pfizer (300 million doses), CureVac (405 million doses) and Moderna (160 million doses). Member States also have the option to donate vaccines to lower and middle income c...